Near-infrared upconversion multimodal nanoparticles for targeted radionuclide therapy of breast cancer lymphatic metastases

HIGHLIGHTS

• who: Chuan Zhang and colleagues from the Tongji University School of Medicine, China have published the research work: Near-infrared upconversion multimodal nanoparticles for targeted radionuclide therapy of breast cancer lymphatic metastases, in the Journal: (JOURNAL)
• what: The authors successfully designed a nanoprobe conjugated trastuzumab based on upconversion nanoparticles, further developed a nanonuclear drug labeled 68Ga or 177Lu, adopted a new imaging and theranostic strategy for lymphatic targeting, to realize the multimodal imaging and theranostics of lymph node metastasis.
• how: These results showed that the nanoprobe had good targeting performance in metastatic lymph . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.